Production (Stage)
BioMarin Pharmaceutical Inc.
BMRN
$57.55
-$0.46-0.79%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.27B | 1.14B | 930.44M | 1.22B | 1.05B |
| Total Receivables | 739.18M | 660.54M | 777.55M | 691.23M | 637.16M |
| Inventory | 1.27B | 1.23B | 1.18B | 1.18B | 1.14B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 181.55M | 201.53M | 169.26M | 160.43M | 163.29M |
| Total Current Assets | 3.47B | 3.23B | 3.06B | 3.26B | 2.99B |
|
|
|||||
| Total Current Assets | 3.47B | 3.23B | 3.06B | 3.26B | 2.99B |
| Net Property, Plant & Equipment | 1.03B | 1.08B | 1.05B | 1.05B | 1.06B |
| Long-term Investments | 196.20M | 196.20M | 196.20M | 196.20M | 196.20M |
| Goodwill | 196.20M | 196.20M | 196.20M | 196.20M | 196.20M |
| Total Other Intangibles | 247.35M | 327.38M | 260.92M | 265.53M | 279.65M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.70B | 1.63B | 1.72B | 1.73B | 1.72B |
| Total Assets | 7.15B | 6.99B | 6.85B | 7.07B | 6.87B |
|
|
|||||
| Total Accounts Payable | 293.75M | 235.40M | 312.32M | 257.41M | 292.24M |
| Total Accrued Expenses | 276.67M | 331.27M | 349.50M | 268.84M | 260.27M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.31M | 7.57M | 8.06M | 505.53M | 502.93M |
| Total Finance Division Other Current Liabilities | 51.48M | 32.74M | 45.78M | 35.56M | 32.47M |
| Total Other Current Liabilities | 51.48M | 32.74M | 45.78M | 35.56M | 32.47M |
| Total Current Liabilities | 628.21M | 606.99M | 715.66M | 1.07B | 1.09B |
|
|
|||||
| Total Current Liabilities | 628.21M | 606.99M | 715.66M | 1.07B | 1.09B |
| Long-Term Debt | 595.65M | 595.14M | 594.63M | 594.12M | 593.61M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 31.26M | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 129.69M | 97.57M | 127.51M | 119.37M | 117.35M |
| Total Liabilities | 1.35B | 1.33B | 1.44B | 1.78B | 1.80B |
|
|
|||||
| Common Stock & APIC | 5.79B | 5.80B | 5.74B | 5.70B | 5.62B |
| Retained Earnings | -9.01M | -194.70M | -319.64M | -425.72M | -532.89M |
| Treasury Stock & Other | 7.97M | 50.43M | -7.07M | 15.13M | -12.75M |
| Total Common Equity | 5.79B | 5.66B | 5.41B | 5.29B | 5.07B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.79B | 5.66B | 5.41B | 5.29B | 5.07B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.79B | 5.66B | 5.41B | 5.29B | 5.07B |
|
|
|||||